1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Scilex Holding Company agreed on July 18, 2026 to sell Vivasor Holding Company shares of Vivasor preferred stock it had acquired in January 2026, for an aggregate price of $11,999,762.28. Payment is scheduled in tranches through June 30, 2027, and Vivasor may pay in cash, in shares of Datavault AI common stock, or a combination. The buyer is led by Scilex CEO Dr. Henry Ji, who is also Vivasor's CEO, a related-party arrangement shareholders may want to weigh.
Agreement dated July 18, 2026; Scilex sells 6,101,468 Series A-1 and 355,919 Series A-2 Vivasor preferred shares
Aggregate purchase price of $11,999,762.28, with $999,980.97 due July 18, 2026 and $4,999,901.10 due on or before September 30, 2026
Remaining installments of $1,999,960.07 each fall due by December 31, 2026, March 31, 2027 and June 30, 2027
Dr. Henry Ji serves as Scilex CEO, President and Chairperson and as CEO of Vivasor
Jones Ventures INTL Acquisition1 Corp, a blank-check company with no target selected, closed its initial public offering of 20,000,000 units at $10.00 per unit on July 15, 2026, for gross proceeds of $200 million. The $200 million was placed in a U.S. trust account, and the company has 21 months from the closing to complete a business combination or return the trust funds to public shareholders.
Initial public offering of 20,000,000 units at $10.00 per unit, generating $200 million in gross proceeds on July 15, 2026
Private placement of 645,000 units to the sponsor and underwriter for $6,450,000
$200 million placed in a trust account at Citibank, N.A., with Equiniti Trust Company, LLC as trustee; underwriters have a 45-day option to buy up to 3,000,000 more units
Company had cash of $1,614,681 as of July 15, 2026, and must complete a business combination within 21 months
The Toro Company said its board elected President and Chief Operating Officer Edric C. Funk as president and chief executive officer, effective November 1, 2026, as part of a planned succession. Richard M. Olson, CEO since November 2016, will become executive chairman on the same date, and Funk joined the board immediately.
Funk was elected by the board on July 21, 2026, joined the company in 1996, and has been president and COO since September 2025.
Funk's annual base salary rises from $715,000 to $1,000,000 effective November 1, 2026, with a fiscal 2027 cash incentive target of 120% of base salary.
Olson's base salary will be $763,000 as executive chairman, with a fiscal 2027 cash incentive target of 130% of base salary, effective November 1, 2026.
The board increased its size from nine to ten directors to seat Funk, whose term ends at the 2027 annual meeting.
Netflix completed a registered public offering of $1 billion in 5.250% senior unsecured notes due 2036 on July 22, 2026. The company plans to use the net proceeds to repay its 4.375% Senior Notes due 2026 at maturity and for general corporate purposes.
Offering size: $1 billion in principal amount of 5.250% senior unsecured notes due 2036
Proceeds to repay outstanding 4.375% Senior Notes due 2026 at maturity, plus general corporate purposes
Sold under shelf registration on Form S-3ASR (File No. 333-281071); underwriters include BNP Paribas Securities Corp. and Morgan Stanley & Co. LLC
On July 22, 2026, DarioHealth agreed to sell 2,437,060 common shares and pre-funded warrants for 1,017,499 shares to institutional investors in a registered direct offering priced at-the-market under Nasdaq rules, for gross proceeds of about $23.5 million before fees. The sale adds new shares outstanding, and the company has agreed not to issue more shares for 30 days after closing, which is expected on or about July 23, 2026, apart from its existing at-the-market facility.
Shares priced at $6.80 each; pre-funded warrants priced at $6.7999 each, covering 1,017,499 shares
Gross proceeds of about $23.5 million; placement agent cash fee of 6.0%, with a 1.0% fee on certain investor proceeds, plus expenses up to $60,000
Board member Dennis Matheis agreed to buy 14,430 shares at $6.93 per share
Company may not issue further shares for 30 days after closing, expected on or about July 23, 2026, except under its existing at-the-market facility and Form S-8 plans
On July 22, 2026, Public Storage said it had closed its acquisition of National Storage Affiliates Trust (NSA), with NSA common shares converted at 0.1400 Public Storage common share each. The company issued about 11.2 million common shares, and a joint venture holding 313 former NSA properties took on about $2.2 billion of debt. Public Storage expects the deal to be accretive to FFO per share within the first year after closing, with accretion rising to $0.35 to $0.50 per share once $110 to $130 million of run-rate synergies are realized over three to four years.
Exchange ratio: each NSA common share became 0.1400 of a Public Storage common share, plus cash for fractional shares
About 11,200,000 Public Storage common shares issued on the closing date
Joint venture of 313 properties, valued at about $3.2 billion, financed with about $2.0 billion mortgage and $237 million mezzanine loan
Expected synergies of $110 to $130 million over three to four years, with accretion of $0.35 to $0.50 per share
On July 22, 2026, Domo's board adopted a tax benefits preservation plan and declared a dividend of one preferred stock purchase right per Class A and Class B common share, held by holders of record on August 4, 2026. The plan aims to deter any person or group from acquiring 4.9% or more of the company's securities, which could trigger an ownership change that limits use of net operating losses. The filing header names Huckleberry.ai, Inc. (HUCK), but the body refers only to Domo, Inc., so the registrant identity should be confirmed.
Board adopted the plan and declared the rights dividend on July 22, 2026; record date is August 4, 2026.
Each right's exercise price is $17.50, subject to adjustment, and the rights expire at the close of business on July 20, 2029, subject to earlier events.
Acquiring Person threshold is 4.9% of outstanding common stock; the plan is not expected to interfere with Board-approved mergers.
Equiniti Trust Company, LLC is named as rights agent.
Supernus Pharmaceuticals said it will report second quarter 2026 financial and business results after the market closes on Tuesday, August 4, 2026. The company will hold a conference call and webcast that day at 4:30 p.m. ET, led by CEO Jack Khattar and CFO Tim Dec. The announcement contains no financial results.
Second quarter 2026 results to be released after market close on August 4, 2026
Conference call and webcast set for August 4, 2026 at 4:30 p.m. ET
Replay to be available on the investor relations website for 60 days after the live call
Trane Technologies said its Senior Vice President and Chief Global Integrated Supply Chain Officer, Mingxiao (Gary) Guo, will leave the company effective August 1, 2026, under a separation agreement. The filing says the departure is not the result of any disagreement with the company on operations, policies, practices, controls or financial matters.
Mingxiao (Gary) Guo's departure is effective August 1, 2026; the decision was made July 20, 2026.
Under the separation agreement, the company is forgoing the clawback of certain sign-on bonus payments made to Mr. Guo.
The filing states the departure is not due to any disagreement on operations, policies, practices, controls or financial matters.
Quantum Computing Inc. appointed Susan G. Hunt as Chief Revenue Officer effective July 17, 2026, succeeding Pouya Dianat, who moved to the newly created Chief Product Officer role. The filing says the move was mutually agreed and that Dianat's compensation was not materially changed. Hunt will lead the company's global revenue strategy, sales execution, and customer growth initiatives as it works to commercialize quantum computing solutions.
Susan G. Hunt, age 64, became Chief Revenue Officer on July 17, 2026, succeeding Pouya Dianat.
Dianat transitioned from CRO to the newly created Chief Product Officer role, effective immediately, focusing on product development.
Hunt previously served as CRO of Orbital Insight from May 2022 to January 2023 and as Senior Vice President of North American Sales at LivePerson from January 2019 to October 2022.
The filing says Dianat's compensation was not materially changed in connection with the transition.
NewHold Investment Corp IV said Chief Financial Officer Polly Schneck resigned effective July 22, 2026, to pursue other professional opportunities, and the board appointed John Boone as CFO effective the same day. The filing says her departure was not due to any disagreement with the company, its board or management. Compensation for Mr. Boone has not been finalized and will be disclosed later if required.
Polly Schneck resigned as CFO effective July 22, 2026; the filing states no disagreement on operations, policies or practices
John Boone appointed CFO effective July 22, 2026, with over a decade of public equity investing experience
Mr. Boone previously worked at Isomer Partners, Schonfeld Strategic Advisors and Scopia Capital Management
Compensation arrangements for Mr. Boone have not been finalized
BETA Technologies received notice on July 14, 2026 that the Defense Counterintelligence and Security Agency ended the Security Control Agreement dated June 15, 2025, which had mitigated foreign ownership and influence concerns tied to QIA Industrials Holding. DCSA determined the agreement was no longer necessary because QIA no longer has a seat on the Company's Board of Directors.
Security Control Agreement dated June 15, 2025 terminated, per DCSA notice received July 14, 2026
Agreement parties: QIA Industrials Holding, LLC, BETA Technologies, and the U.S. Department of Defense
Reason given: QIA no longer has board representation at the Company
Wynn Resorts disclosed that the Macau Government published an amended and restated land concession contract for its Cotai Land on July 22, 2026 Hong Kong time. The amendment permits Wynn Palace to expand with a new five-star hotel, a theater and an event and entertainment center. Palo must pay a one-time additional land premium of approximately $80.8 million, which the Macau subsidiary's announcement says will be paid out of available cash.
One-time additional land premium of MOP652.3 million (approximately $80.8 million), paid upon acceptance of the conditions and satisfied out of available cash
Total annual rent for the Expanded Resort of MOP9.5 million (approximately $1.2 million), subject to review every five years
Palo has a maximum of 60 months from publication to complete development of the Expanded Resort
Lease on the Cotai Land runs from May 2, 2012 until May 1, 2037, with renewal rights subject to applicable legislation
Vita Coco completed its acquisition of Copra, Inc. on July 22, 2026, with Copra becoming a wholly-owned subsidiary. Closing consideration was $175 million, paid partly in cash and partly in Vita Coco common stock, with up to $100 million more tied to Copra's 2028 results. The filing states that the acquisition does not materially affect Vita Coco's long-term Adjusted EBITDA margin target.
Closed July 22, 2026; Copra survives as a wholly-owned subsidiary of Vita Coco.
Closing consideration of $175 million: $140,000,210.59 in cash and 467,071 shares of Vita Coco common stock.
Earnout of at least $45 million and at most $100 million, based on Copra's 2028 Gross Profit, payable in cash, stock or both at Vita Coco's discretion.
Copra expects full-year 2026 Net Sales greater than $100 million; Vita Coco reports no change to its long-term financial targets.
Jackson Financial said its board approved Don Cummings as chief executive officer, president and director, and Brian Walta as executive vice president and chief financial officer, both effective October 1, 2026. CEO Laura Prieskorn will retire from her roles and as a director at the end of September 30, 2026, and will serve as an advisor through December 31, 2026. The filing reports pay terms for both new executives but no changes to financial results or guidance.
Don Cummings, currently CFO, becomes CEO and president effective October 1, 2026, with a base salary of $1.05 million, a 200% target bonus and a $7.85 million target long-term incentive award.
Laura Prieskorn retires as CEO, president and director at the end of September 30, 2026, and is expected to advise the company through December 31, 2026.
FutureCorp Space Acquisition 1 said unit holders may elect to separately trade the Class A ordinary shares and warrants starting July 27, 2026. Units not separated will keep trading on the NYSE as FTRAU, and the separated shares and warrants are expected to trade as FTRA and FTRAW, so the change affects how existing holders can trade their positions rather than the company's finances.
Separate trading of Class A ordinary shares and warrants begins July 27, 2026
Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable at $11.50 per share
No fractional warrants will be issued; only whole warrants will trade
Holders must have their brokers contact Continental Stock Transfer & Trust Company to separate units
Rayonier Advanced Materials said its Senior Vice President, General Counsel and Corporate Secretary, R. Colby Slaughter, notified the company on July 20, 2026 that he will resign effective August 7, 2026, to pursue another professional opportunity. The filing does not name a successor or interim replacement.
Colby Slaughter, Senior Vice President, General Counsel and Corporate Secretary, gave notice on July 20, 2026.
Resignation takes effect August 7, 2026.
He is leaving to pursue another professional opportunity; no successor is named in the filing.
Guidewire's board appointed Alexander Vollert, a former chief operating officer of AXA SA, as a director effective August 1, 2026. The filing also discloses that Guidewire recognized revenue from AXA SA and its affiliates in fiscal 2025 and in the nine months ended April 30, 2026, which is relevant because Dr. Vollert was an AXA executive until December 2025.
Board appointment made July 17, 2026, effective August 1, 2026; initial term runs through the 2026 annual meeting, subject to re-election.
Dr. Vollert was chief operating officer of AXA SA from December 2021 to December 2025 and CEO of AXA Germany from September 2016 to November 2021.
Guidewire recognized about $13.4 million in revenue from AXA SA and affiliates for the nine months ended April 30, 2026, and about $11.3 million in fiscal 2025 (year ended July 31, 2025).
American Healthcare REIT said Danny Prosky retired as CEO and President effective July 21, 2026, and the board named Jeff Hanson CEO that day; Hanson, who had been interim CEO since February 2026, also remains Chairman. Prosky stays on the board, and Gabe Willhite was elevated to President while remaining Chief Operating Officer, which changes who runs day-to-day operations and sets new pay terms for the top executives.
Jeff Hanson named CEO effective July 21, 2026; he continues as Chairman. His base salary is $965,000 and his target annual bonus is 160% of base salary.
Hanson received two equity grants, each with a grant date fair value of $2,072,534: time-based RSUs vesting over three years and performance-based RSUs cliff-vesting December 31, 2028.
Danny Prosky's release of claims agreement provides a $35,000 lump sum for continuation medical coverage and accelerated vesting of an unvested restricted stock award scheduled to vest February 9, 2028.
Gabe Willhite was named President and Chief Operating Officer, with a $100,000 cash pay increase and target bonus raised to 125% of base pay; Scott Estes was named Lead Independent Director with a $40,000 added annual retainer.
Target's Board of Directors elected Joe DePinto, former president and CEO of 7-Eleven, Inc., as a director on July 18, 2026, effective August 1, 2026. The filing says he will also serve on the Audit & Risk Committee and the Infrastructure & Finance Committee and will receive the standard non-employee director pay described in Target's 2026 proxy statement. The filing reports no financial results or other financial figures.
Joe DePinto elected to Target's Board by the Board on July 18, 2026, effective August 1, 2026
Appointed to the Audit & Risk Committee and the Infrastructure & Finance Committee, both effective August 1, 2026
DePinto, 63, was CEO of 7-Eleven, Inc. from 2005 to December 2025; the filing names prior roles at GameStop and PepsiCo
Filing states no related person transactions with Target and no arrangements under which he was selected
STAG Industrial and its operating partnership entered into an amended term loan agreement dated July 16, 2026, combining its $150 million Unsecured Term Loan A and $200 million Unsecured Term Loan F into one $350 million senior unsecured loan. The new loan matures January 16, 2032, and its spread is reduced by five basis points. The company also amended its $1.0 billion unsecured credit facility and three term loans to cut their spreads by five basis points, with the filing stating the other terms are unchanged.
Unsecured Term Loan A ($150 million, due March 15, 2027) and Unsecured Term Loan F ($200 million, due March 25, 2029, assuming extensions) were combined into one $350 million loan maturing January 16, 2032.
The spread on the combined loan and on the $1.0 billion unsecured credit facility and Unsecured Term Loans G, H and I was reduced by five basis points, with the spread still tied to debt rating and leverage ratio.
As of July 20, 2026, $150 million was swapped to 2.01% until March 15, 2027, then 4.79% until January 16, 2032; $200 million was swapped to 4.68% until March 25, 2027, then 4.79% until January 16, 2032.
The amendments were signed on July 16, 2026, with Wells Fargo Bank, National Association, and other lenders.
Intellicheck said Chief Technology Officer Jonathan Robins will leave the company for personal family reasons. He is on unpaid leave from July 18, 2026, and his employment ends October 16, 2026. The filing describes healthcare and COBRA coverage the company will pay for, but it does not name a successor or cite any financial impact.
Jonathan Robins notified the company on July 16, 2026 of his decision to separate as Chief Technology Officer, effective July 18, 2026.
Robins is on unpaid leave from July 18, 2026; his final day of employment is October 16, 2026.
The company will pay the full cost of Robins's benefits during leave and COBRA continuation coverage from November 1, 2026 through March 31, 2027.
The full memorandum of understanding will be filed with the quarterly report for the quarter ended September 30, 2026.
Shenandoah Telecommunications said Vice President and Chief Accounting Officer Tracy Willis notified the company on July 20, 2026 that she will resign effective August 6, 2026. CFO James Volk will take on the role of principal accounting officer while continuing as principal financial officer, and the filing states her departure was not due to any disagreement with the company.
Tracy Willis, Vice President and Chief Accounting Officer, notified the company of her resignation on July 20, 2026
Resignation is effective August 6, 2026
James Volk, Senior Vice President and CFO, will become principal accounting officer upon her departure and keep the principal financial officer role
The filing states the departure was not the result of any disagreement with the company
QuantumScape's subsidiary amended its collaboration agreement with PowerCo, Volkswagen Group's battery cell company, on July 16, 2026. The amendment replaces the prior statement of work and cost reimbursement structure with milestone-based payments, with a maximum aggregate amount of $75.4 million inclusive of amounts paid to date. Shareholders may track how the milestone-linked payments and the transfer of QSE-5 Technology progress.
Amendment dated July 16, 2026 updates program structure and milestones for QSE-5 Technology development and initial commercialization
Maximum aggregate amount the Company will receive from PowerCo for the program is $75.4 million, including amounts paid to date
Statement of Work No. 1 was terminated effective July 16, 2026 and replaced by the Amendment; outstanding invoiced obligations remain payable to the Company
Corvus Pharmaceuticals said director Ian T. Clark gave notice on July 21, 2026 that he will resign from its board, effective July 22, 2026. The company thanked him for more than nine years of board service, and the filing gives no replacement or reason for the departure.
Ian T. Clark delivered resignation notice on July 21, 2026.
Resignation is effective July 22, 2026.
Clark served on the board for over nine years, according to the company.
Credit Acceptance said director Kenneth S. Booth resigned from its board on July 21, 2026, and that the resignation was not due to any disagreement with the company, management, or the board. The board reduced its size from six directors to five in connection with his departure.
Kenneth S. Booth notified the company of his board resignation on July 21, 2026.
The filing states the resignation was not due to any disagreement with the company, its management, the Board or any committee.
The board size was reduced from six directors to five.
Red Cat Holdings' board determined that Chief Revenue Officer Geoffrey Hitchcock was terminated for cause, effective July 23, 2026, and that he is not entitled to severance or accelerated equity vesting. On July 21, 2026, Mr. Hitchcock filed a civil complaint against the company seeking damages in an unspecified amount, which the company says is without merit.
Termination of Chief Revenue Officer Geoffrey Hitchcock is effective July 23, 2026, based on a for-cause determination made July 17, 2026.
Mr. Hitchcock is not entitled to severance or acceleration of equity vesting, except for salary and benefits earned through the termination date.
Mr. Hitchcock filed a civil complaint on July 21, 2026, alleging retaliatory termination, breach of contract and breach of the implied covenant of good faith; damages are unspecified.
The company says the claims are without merit and will evaluate potential counterclaims.
Kensington Capital Acquisition Corp. VI, a special purpose acquisition company, signed a business combination agreement on July 21, 2026, with critical minerals refiner Nth Cycle, Inc. Kensington will become a Delaware corporation renamed Nth Cycle Holdings, Inc., and its shares are expected to trade on the NYSE under the symbol NTH. The deal is expected to close in the fourth quarter of 2026, subject to shareholder approvals and other conditions, and implies a pro forma enterprise value of approximately $585 million.
Business combination agreement signed July 21, 2026; closing expected in the fourth quarter of 2026, subject to Kensington shareholder and Nth Cycle stockholder approvals
Implied pro forma enterprise value of approximately $585 million, assuming no Kensington redemptions
Up to $230 million in Kensington trust proceeds, subject to redemptions, plus a common stock PIPE of up to $100 million, with $40 million committed to date
Nth Cycle holders to receive New Nth Cycle common stock based on 50,700,200 shares divided by fully diluted capital, plus up to 20,000,000 earnout shares
Apex Treasury Corp, a blank check company listed on Nasdaq as APXT, signed a business combination agreement with AI data center developer TECfusions, Inc. that values TECfusions at $4.0 billion. The deal would make TECfusions a publicly traded company, expected to trade as TECF, with closing anticipated in the fourth quarter of 2026 subject to Apex shareholder approval and other conditions.
Equity valuation of $4.0 billion; 400.0 million new shares of common stock issued to TECfusions stockholders at $10.00 per share
$35 million private placement (PIPE) from an institutional investor at the same $10.00 per share valuation
Closing requires Apex shareholder approval and at least $45.0 million in Available Closing Cash; outside termination date is March 31, 2027
Joint investor webinar scheduled for Tuesday, July 28, 2026 at 11:00am Eastern Time
Inspire Medical Systems said director Casey Tansey, a board member for more than eighteen years, will retire from the board effective July 30, 2026, and will not stand for re-election at the 2027 Annual Meeting. The company said the decision was not the result of any disagreement with the company or any matter relating to its operations, policies or practices, and it expects to name a replacement director in the near future.
Casey Tansey's retirement from the board and its committees is effective July 30, 2026.
Tansey led the Series A financing in November 2007 for U.S. Venture Partners and has served on the board since then.
The company said it expects to announce a new director to replace Tansey in the near future.
Monopar Therapeutics said it has begun a rolling submission of a New Drug Application to the FDA for ALXN1840 (tiomolibdate choline) for Wilson disease, and has submitted its first completed sections. The filing is a regulatory milestone; approval is not assured, and the company says the drug could receive a pediatric Priority Review Voucher if approved.
Monopar has initiated a rolling NDA submission for ALXN1840 with the FDA and has submitted the first completed sections.
The FDA authorized the rolling submission, which lets completed sections be reviewed while remaining sections are finalized.
ALXN1840 received Rare Pediatric Disease designation from the FDA in June 2026, which could allow a pediatric Priority Review Voucher at approval.
FirstCash Holdings announced that CEO and Vice Chairman Rick Wessel will become Executive Chairman and step down as CEO effective January 1, 2027, with President and COO Brent Stuart succeeding him as CEO on that date. The board also elected Stuart as a director effective July 22, 2026, and Chairman Dan Feehan will retire from the chairmanship on the transition date while remaining on the board. Stuart's and Wessel's compensation has not yet been determined and will be disclosed in a future amendment.
Rick Wessel moves from CEO to Executive Chairman effective January 1, 2027, and expects to serve on the board for at least three years.
Brent Stuart, 56, President and COO since September 2016, will become CEO effective January 1, 2027, and keep direct responsibility for day-to-day operations.
Stuart was elected to the board effective July 22, 2026, and will not receive separate board compensation.
Dan Feehan will retire as Chairman of the Board on January 1, 2027, and remain a board member.
BD said Executive Vice President Michael Garrison, president of the Medical Essentials and BioPharma Systems segments, will retire after more than 20 years with the company. BD is searching for his successor as president of Medical Essentials, and BioPharma Systems will report directly to CEO Tom Polen to streamline the operating model.
Garrison informed BD of his retirement intention on July 19, 2026, and the press release gives an effective date of Oct. 2.
The filing says Garrison will stay in his role through the end of the fiscal year to support a smooth transition.
A comprehensive search is underway for the next president of Medical Essentials.
BioPharma Systems will report directly to Chairman, CEO and President Thomas E. Polen.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.